Funding For ‘Holy Grail’ Of Anticoagulant Drugs, University Of Cambridge
XO1 Ltd, a University of Cambridge and Addenbrooke’s Hospital spin-out company, has raised $11 million in funding to develop a Source: Health News
Continue Reading →Posted in: AICHC News
Leave a Comment (0) →